Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1
- 1 August 1993
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (5) , 397-401
- https://doi.org/10.1016/0002-9149(93)91129-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemiaThe American Journal of Medicine, 1991
- Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemiaAmerican Heart Journal, 1990
- Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose ToleranceNew England Journal of Medicine, 1989
- Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery diseaseEuropean Heart Journal, 1989
- Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.Heart, 1988
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjectsMetabolism, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Plasminogen activator inhibitor in the blood of patients with coronary artery disease.BMJ, 1985
- Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in FinlandDiabetes Care, 1979